Fernando Maluf
Fernando Maluf is a Brazilian oncologist and the leader of a significant study on prostate cancer survival rates, which revealed that patients treated in the private healthcare system live, on average, two years and four months longer than those treated in the public system (SUS). His research highlights the disparities in access to advanced treatments and aims to inform public health policies to address these inequalities.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Brazil | 2 | 8.50 | 0.12% | +10% | 211,049,527 | 270,419 | $1,500,000 | 1,922$ |
| Liechtenstein | 1 | 7.00 | 0.07% | +0% | 38,137 | 27 | $6,900 | 5$ |
| Totals | 3 | 211,087,664 | 270,446 | $1,506,900 | 1,927$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Liechtenstein:
Fernando Maluf is a co-founder of the Instituto Vencer o Câncer and discusses the relationship between stress and cancer.
7
Brazil:
Fernando Maluf is an oncologist and founder of the Institute Vencer o Câncer.
8
Brazil:
Fernando Maluf is an oncologist who emphasizes the importance of multidisciplinary approaches in cancer treatment.
9
Liechtenstein:
Fernando Maluf, cofounder of the Instituto Vencer o Câncer, discusses the relationship between stress and cancer.
8
Liechtenstein:
Fernando Maluf is the leader of the study on prostate cancer survival rates between private and public healthcare systems.
8